ContractopenCO
TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.
National Institutes of HealthDescription
TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES. Recipient: CRESTONE, INC. Award Amount: $20.48M
Requirements
Source: USASpending.gov
Interested in this contract?
Sign up to get match scores, track opportunities, and manage proposals with AI-powered tools.
Contract Details
Value Range
Up to $20,480,000
Deadline
August 19, 2026
Geographic Scope
CO
Status
open
External Links
View Original ListingSee how well this contract matches your organization.
Get Your Match Score